Ecraprost

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameEcraprost
Drug Alias Name依克前列素Circulase艾克前列素ecraprostecraprostum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP1 receptor agonists
TargetsProstanoid EP1 receptor
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe PharmaAsahi Glass Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma Corp
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksKEGG